TY - JOUR T1 - Current biology of VEGF-B and VEGF-C JF - Curr Opin Biotechnol Y1 - 1999 A1 - Olofsson, B A1 - Jeltsch, M A1 - Eriksson, U A1 - Alitalo, K AB - Endothelial growth factors and their receptors may provide important therapeutic tools for the treatment of pathological conditions characterised by defective or aberrant angiogenesis. Vascular endothelial growth factor (VEGF) is pivotal for vasculogenesis and for angiogenesis in normal and pathological conditions. VEGF-B and VEGF-C provide this gene family with additional functions, for example, VEGF-C also regulates lymphangiogenesis. VL - 10 UR - http://view.ncbi.nlm.nih.gov/pubmed/10600689 IS - 6 JO - Current Opinion in Biotechnology ER -